These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33949229)

  • 21. Helicobacter pylori eradication - an update on the latest therapies.
    Yaxley J; Chakravarty B
    Aust Fam Physician; 2014 May; 43(5):301-5. PubMed ID: 24791773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NSAID use and abuse in gastroenterology: refractory peptic ulcers.
    Lanas A
    Acta Gastroenterol Belg; 1999; 62(4):418-20. PubMed ID: 10692772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori.
    Yazbek PB; Trindade AB; Chin CM; Dos Santos JL
    Dig Dis Sci; 2015 Oct; 60(10):2901-12. PubMed ID: 25999247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy--optimisation is the way forward.
    Molina-Infante J; Gisbert JP
    Aliment Pharmacol Ther; 2013 Jul; 38(2):204-5. PubMed ID: 23772902
    [No Abstract]   [Full Text] [Related]  

  • 25. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.
    Soll AH
    JAMA; 1996 Feb; 275(8):622-9. PubMed ID: 8594244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Good bugs and bad bugs: indications and therapies for Helicobacter pylori eradication.
    Kuipers EJ; Janssen MJ; de Boer WA
    Curr Opin Pharmacol; 2003 Oct; 3(5):480-5. PubMed ID: 14559092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection.
    Ramsoekh D; van Leerdam ME; Rauws EA; Tytgat GN
    Clin Gastroenterol Hepatol; 2005 Sep; 3(9):859-64. PubMed ID: 16234022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy--optimisation is the way forward; authors' reply.
    Sierra F; Forero JD; Rey M; Botero ML; Cárdenas A
    Aliment Pharmacol Ther; 2013 Jul; 38(2):205-6. PubMed ID: 23772903
    [No Abstract]   [Full Text] [Related]  

  • 29. No Helicobacter pylori, no Helicobacter pylori-associated peptic ulcer disease.
    Tytgat GN
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():39-42. PubMed ID: 7495941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Helicobacter pylori positivity in patients undergoing percutaneous coronary intervention.
    Hiew C; Duggan A; de Malmanche T; Hatton R; Baker F; Attia J; Collins N
    Intern Med J; 2012 Mar; 42(3):289-93. PubMed ID: 20492005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
    Satoh K; Yoshino J; Akamatsu T; Itoh T; Kato M; Kamada T; Takagi A; Chiba T; Nomura S; Mizokami Y; Murakami K; Sakamoto C; Hiraishi H; Ichinose M; Uemura N; Goto H; Joh T; Miwa H; Sugano K; Shimosegawa T
    J Gastroenterol; 2016 Mar; 51(3):177-94. PubMed ID: 26879862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users].
    Shimada T; Yamagata M; Hiraishi H
    Nihon Rinsho; 2007 Oct; 65(10):1824-9. PubMed ID: 17926531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
    Guevara B; Cogdill AG
    Dig Dis Sci; 2020 Jul; 65(7):1917-1931. PubMed ID: 32170476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early eradication has a lower risk of peptic ulcer bleeding in Helicobacter pylori-infected chronic kidney disease patients.
    Hsu CH; Hu HY; Huang N; Chang SS
    Eur J Intern Med; 2016 Sep; 33():112-7. PubMed ID: 27449117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
    Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
    Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptic ulcers. Stopping them for good.
    Mayo Clin Health Lett; 2011 Mar; 29(3):1-3. PubMed ID: 21553705
    [No Abstract]   [Full Text] [Related]  

  • 38. Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication.
    Tan AC; Hartog GD; Mulder CJ
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1519-22. PubMed ID: 10571610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines in the medical treatment of Helicobacter pylori infection.
    Dzieniszewski J; Jarosz M
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer.
    Ng TM; Fock KM; Khor JL; Teo EK; Sim CS; Tan AL; Machin D
    Aliment Pharmacol Ther; 2000 Feb; 14(2):203-9. PubMed ID: 10651661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.